KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Short term Debt (2019 - 2025)

Hims & Hers Health's Short term Debt history spans 7 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Short term Debt changed N/A year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, changed N/A, while the annual FY2025 figure was $3.6 million, N/A changed from the prior year.
  • Short term Debt for Q4 2025 was $3.6 million at Hims & Hers Health, down from $7.4 million in the prior quarter.
  • Across five years, Short term Debt topped out at $42.8 million in Q4 2021 and bottomed at $3.6 million in Q4 2025.
  • The 5-year median for Short term Debt is $10.2 million (2022), against an average of $13.5 million.
  • The largest annual shift saw Short term Debt skyrocketed 5643.71% in 2021 before it tumbled 63.18% in 2023.
  • A 5-year view of Short term Debt shows it stood at $42.8 million in 2021, then tumbled by 69.72% to $13.0 million in 2022, then crashed by 42.86% to $7.4 million in 2023, then changed by 0.0% to $7.4 million in 2024, then tumbled by 50.81% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Short term Debt are $3.6 million (Q4 2025), $7.4 million (Q1 2024), and $7.4 million (Q4 2023).